Take Q2 Results 2026: PAT ₹2 Cr −64.9%, Revenue ₹29 Cr
Q2 FY27 results statement: what the company reported on revenue, margins and capex.
- Revenue
- ₹29Cr
- Q2 FY26: ₹0 Cr
- −3.1% QoQ
- Net profit
- ₹2Cr
- −64.9% YoY
- +108.5% QoQ
- Margin
- 6.1%
- +7 pp QoQ
Top 10 Healthcare Services companies on management guidance
See the sector's top 10 — free with your mobile number.
Take Ltd Q2 FY27 key numbers
- Revenue
- Standalone revenue from operations for the same quarter was Rs. 1,431.98 lakhs, also compared to Rs. 0 in the previous year quarter.
As stated in Take Ltd's Q2 FY27 results statement · published 14 Nov 2026. Reported figures, not investment advice.
Based on Take Ltd's Q2 FY27 results statement. The company has not published an earnings-call transcript for this quarter, so figures here are what the results statement reports, not management guidance.
The short version
For the quarter ended September 30, 2026, TAKE Limited reported consolidated revenue from operations of Rs. 2,941.68 lakhs versus Rs. 0 for the corresponding quarter in the previous year, indicating a. EBITDA for the quarter is ₹ 62.9 million, up 304% year-on-year (YoY).
From Take Ltd's Q2 FY27 earnings-call transcript · updated 14 Nov 2026.
How did Take's revenue grow in the September 2026 quarter?
- For the quarter ended September 30, 2026, TAKE Limited reported consolidated revenue from operations of Rs. 2,941.68 lakhs versus Rs. 0 for the corresponding quarter in the previous year, indicating a significant year-on-year increase.
- Standalone revenue from operations for the same quarter was Rs. 1,431.98 lakhs, also compared to Rs. 0 in the previous year quarter.
What happened to Take's margins in Q2 FY27?
See what Take Ltd said on profitability & margins — free account, 30 seconds.
What capex is Take planning?
See what Take Ltd said on capital expenditure plans — free account, 30 seconds.
Top-ranked in Healthcare Services
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Is Take raising money or cutting debt?
See what Take Ltd said on fundraising & capital structure — free account, 30 seconds.
How big is Take's order book?
See what Take Ltd said on order book & pipeline — free account, 30 seconds.
Take Ltd — Quarterly revenue & net profit
Take Ltd Q2 FY27 results — key figures
| ₹ Cr | Q2 FY27 | Q2 FY26 | YoY | Q1 FY27 | QoQ |
|---|---|---|---|---|---|
| Revenue | 29 | 0 | — | 30 | -3.1% |
| Operating profit (EBITDA) | 2 | -0 | — | -0 | — |
| Operating margin | 6.1% | — | — | -0.9% | +7 pp |
| Profit before tax | 2 | -0 | — | 1 | +108.5% |
| Net profit (PAT) | 2 | 6 | -64.9% | 1 | +108.5% |
| EPS (₹) | 0.15 | 0.43 | -65.1% | 0.07 | +114.3% |
Source: Take Ltd's results filing to NSE (consolidated), ₹ crore.
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹29 Cr, net profit ₹2 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →More Q2 FY27 results in Healthcare Services
Continue your research
What Take's management said in earlier quarters
Others in Healthcare Services this season
- Chandan Healthca (Q2 FY27)
Q2 FY27 operating income: ₹57.94 Cr, up 45.04% YoY from ₹39.95 Cr (Page 8) . Key investor presentation takeaways from Chandan Healthcare Ltd's Q2 FY27 investor
- Invicta Diagnostic (Q2 FY27)
Revenue from operations for the half year ended September 30, 2026: ₹379.11 lakhs (Page 4). Key results statement takeaways from Invicta Diagnostic Ltd's Q2 FY2
- Unihealth Hosp (Q2 FY27)
1,270 million with a year-on-year (YoY) growth of 6.3% . Key results statement takeaways from Unihealth Hospitals Ltd's Q2 FY27 results statement — and how it r
- Sangani Hospital (Q2 FY27)
1008.56 lakhs (~11.8% increase). Key results statement takeaways from Sangani Hospitals Ltd's Q2 FY27 results statement — and how it ranks against sector peers.
Potential multibaggers · Q2 FY27
Potential multibaggers in Healthcare Services
on management's own guidance
- Strong growth2
- Strong growth1
- IndegeneGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Take Ltd and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Take Ltd Q2 FY27 results?
Take reported net profit of ₹2 Cr (−64.9% YoY) on revenue of ₹29 Cr in Q2 FY27.
What is Take Ltd share price analysis?
Take Ltd currently shows a neutral. The stock trades at a P/E of 32.5 with a market cap of ₹192 Cr. Investors should review the full earnings analysis for detailed insights.
Keep Take Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's results statement. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
